Rankings
▼
Calendar
PRGO Q2 2018 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q2 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.2B
-4.2% YoY
Gross Profit
$471M
39.7% margin
Operating Income
$95M
8.0% margin
Net Income
$36M
3.1% margin
EPS (Diluted)
$0.26
QoQ Revenue Growth
-2.5%
Cash Flow
Operating Cash Flow
$82M
Free Cash Flow
$62M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$11.2B
Total Liabilities
$5.3B
Stockholders' Equity
$5.9B
Cash & Equivalents
$527M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$1.2B
-4.2%
Gross Profit
$471M
$505M
-6.7%
Operating Income
$95M
$149M
-36.4%
Net Income
$36M
-$70M
+152.0%
Revenue Segments
Consumer Self-Care Americas
$597M
50%
Consumer Self-Care International
$381M
32%
RX Pharmaceuticals
$209M
18%
Geographic Segments
UNITED STATES
$772M
65%
Europe
$344M
29%
Other Geographical Areas
$70M
6%
IRELAND
$5M
0%
← FY 2018
All Quarters
Q3 2018 →